Sign in
Taking people in United StatesNo phase

Long-term tracking of people with gastroparesis and their treatment outcomes

Follows people with gastroparesis over time, including those given different treatments.

Key facts

Who runs it
University of Louisville
Where
Louisville, United StatesSee the site
Trial code
Registry title
Gastroparesis Outcome Longitudinal Database Enrolled Numerically
Status
Recruiting
People taking part
3,000 people, planned
Started
1 Jan 2013
Expected to end
1 Jan 2028
Type of study
Observational
Treatments tested
  • GI Neuromodulation
  • Immunotherapy
  • Pyloric Therapies
Record updated
20 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with symptoms of gastroparesis (a slow-emptying stomach) that do not get better with drugs. It is a long-term database that follows patients over time.

Sex
All sexes can join.
Disease stage
Symptoms of gastroparesis that do not respond to drug treatment, with poor nutrition shown by a standard assessment.
Earlier treatment
Drug treatment for gastroparesis has not worked.

Main reasons for not taking part

  • A physical blockage in the digestive tract
  • Pregnancy
  • The patient or guardian cannot sign consent, when consent is needed
  • Mental health conditions that prevent assessment and treatment of the stomach and bowel condition

The registry criteria, word for word

Show all 9 criteriaShow less

Other criteria

  • Inclusion:
  • Patients with the symptoms (Sx) of drug refractory gastroparesis
  • Disordered nutrition by standardized assessment
  • Ability to assess current symptom status
  • Ability to measure other medical conditions; Exclusion:
  • Anatomic obstruction of the GI Tract
  • Pregnancy
  • Inability of patient or guardian to sign informed consent, if needed
  • Psychiatric disorders precluding assessment and treatment of the patient's GI condition

Where in United States

  • University of LouisvilleLouisville, United StatesContact: Thomas Abell, MDTaking people

About the trial

What the trial wants to find out

GOLDEN is a longitudinal database of patients with the symptoms (Sx) of gastroparesis (Gp) who were seen and recorded at the University of Louisville from 2012 and is ongoing. Patients are enrolled and followed by sequential numbers and may include legacy patients seen at other centers by some of the same team and who are reported as part of the series. Outcome relate to patients Sx, survival, quality of life and other measures as detailed below, over time. The study tracks patients regardless of treatment but specifically focuses on GI Neuromodulation (gastric electrical stimulation - GES), Immunotherapy (IVIG), and Pyloric therapies (pyloroplasty, endoscopic). If treatments were administered GOLDEN allows for examination and stratification of outcome by groups both at baseline and at follow up.

The group in the trial

  • People presenting with the Sx of Gp

    People presenting with the symptoms of gastroparesis. The three main interventions are GI neuromodulation, immunotherapy, and pyloric therapies.

    Treatment: GI Neuromodulation, Immunotherapy, and Pyloric Therapies

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Gastroparesis Outcome Longitudinal Database Enrolled Numerically
Plain-language title
Long-term tracking of people with gastroparesis and their treatment outcomesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Publications
Record updated
20 April 2026